Cargando…
Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms
Prostate cancer (PCa) is a major health risk for older men worldwide. Existing systemic therapies mostly target androgen receptor (AR). Although treatments are initially effective, the disease always recurs. A potential mechanism for the treatment failure is that PCa contains, in addition to the AR-...
Autores principales: | Huang, Yu-Hua, Zhang, Ya-Qun, Huang, Jiao-Ti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498729/ https://www.ncbi.nlm.nih.gov/pubmed/30924452 http://dx.doi.org/10.4103/aja.aja_128_18 |
Ejemplares similares
-
Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms
por: Butler, William, et al.
Publicado: (2021) -
Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014) -
Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
por: Zhao, Yicheng, et al.
Publicado: (2019) -
Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression
por: Feng, Ninghan, et al.
Publicado: (2019) -
Cancer-cell-intrinsic mechanisms shaping the immunosuppressive landscape of prostate cancer
por: Zhu, Yini, et al.
Publicado: (2022)